Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Abenomics strategy pays off
Japan’s “Abenomics” strategy of pumping trillions into its stagnant economy and ramping up public spending is paying off as the growth picture improves.The government said its latest monthly snapshot showed the economy was “gradually recovering” as exports and factory outputs rise, driven by the steep fall in the yen.
HSBC board chief is set to step down
John Thornton, the former Goldman Sachs president who specialises in Chinese affairs, is stepping down from the board of HSBC to spend more time on his other business interests. Mr Thornton, who heads HSBC’s remuneration committee, will not seek re-election to the bank’s board at its annual shareholder meeting on Friday.
Actavis to buy Warner Chilcott
Actavis, the US drugs giant, has announced a $5bn (£3.3bn) deal to expand its portfolio of branded drugs by buying the Dublin pharmaceuticals company Warner Chilcott. The deal will dampen speculation Actavis itself might be the subject of a takeover, following reports that it had been approached by Canada’s Valeant Pharmaceuticals.
New rules bring home the bacon
Food scares and stricter pig production rules across Europe will be good for bacon, sausage and cooked meats group Cranswick, its chairman said yesterday. Cranswick’s headline profits rose 8 per cent to £49.3m in the year to March on sales 7 per cent ahead at £875m. Fastest growth came from premium hand cured, air-dried bacon.
Mixture of names at Whiteley centre
The property giant British Land has revealed that a number of independent retailers will trade alongside the high street’s biggest names at its shopping centre in Fareham, Hampshire, which opens on Thursday. The Whiteley scheme has a market square surrounded by seven shops.
Great Portland leases to law firm
Property firm Great Portland Estates scored a major City tenant yesterday as the international law firm Bird & Bird agreed to lease the whole of its 12-14 New Fetter Lane scheme, due to be completed in 2015. Bird & Bird will pay an average of £58.80 a square foot, ahead of the average for the Square Mile.
Elan lands new drug deal
The drug-maker Elan has announced another major drug deal and launched a share buyback scheme as it protects itself from a $5.7bn (£3.7bn) bid from Royalty Pharma of the US. The Irish medicine-maker will tie-up with rare drug specialist AOP Orphan.
Winkworth sets up agency in India
Estate agents Winkworth is dipping its toe into the Indian property market with a new office in Bangalore. The firm has signed a deal with former Royal Bank of Scotland investment banker Narayanan Soundararajan as it aims to establish Winkworth-franchised offices across India.
Legal & General in £70m pubs sale
Legal & General’s property arm has completed a sale and leaseback purchase of a portfolio of 27 Marston’s pubs for just under £70 million. The properties are all let to the pub group on long, inflation-linked, leases and have been purpose built for the chain.
Tate & Lyle in Biovelop deal
Tate & Lyle has acquired Biovelop, a Swedish maker of oat beta-glucan. Under the brand name PromOat, its products are used in the food, beverage and supplement markets, and under the brand name Avenacare for use in the cosmetics industry.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments